BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33013205)

  • 1. Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays.
    Sadeghi F; Asgari M; Matloubi M; Ranjbar M; Karkhaneh Yousefi N; Azari T; Zaki-Dizaji M
    Biol Proced Online; 2020; 22():23. PubMed ID: 33013205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation.
    Baert A; Depuydt J; Van Maerken T; Poppe B; Malfait F; Storm K; van den Ende J; Van Damme T; De Nobele S; Perletti G; De Leeneer K; Claes KB; Vral A
    Breast Cancer Res; 2016 May; 18(1):52. PubMed ID: 27184744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay.
    Baert A; Depuydt J; Van Maerken T; Poppe B; Malfait F; Van Damme T; De Nobele S; Perletti G; De Leeneer K; Claes KB; Vral A
    Oncol Rep; 2017 Mar; 37(3):1379-1386. PubMed ID: 28184943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay.
    Ernestos B; Nikolaos P; Koulis G; Eleni R; Konstantinos B; Alexandra G; Michael K
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1199-205. PubMed ID: 20206018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
    Speit G; Trenz K
    Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers.
    Baeyens A; Thierens H; Claes K; Poppe B; de Ridder L; Vral A
    Int J Radiat Biol; 2004 Oct; 80(10):745-56. PubMed ID: 15799620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes
    Zuhair Kassem T; Wunderle M; Kuhlmann L; Ruebner M; Huebner H; Hoyer J; Reis A; Fasching PA; Beckmann MW; Hack CC; Fietkau R; Distel L
    Curr Issues Mol Biol; 2023 Aug; 45(8):6618-6633. PubMed ID: 37623237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.
    Gutiérrez-Enríquez S; Ramón Y Cajal T; Alonso C; Corral A; Carrasco P; Cornet M; Sanz J; Ribas M; Baiget M; Diez O
    Breast Cancer Res Treat; 2011 Jun; 127(3):611-22. PubMed ID: 20625817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal radiosensitivity of triple negative breast cancer patients.
    Francies FZ; Herd O; Cairns A; Nietz S; Murdoch M; Slabbert J; Claes KBM; Vral A; Baeyens A
    Int J Radiat Biol; 2019 Nov; 95(11):1507-1516. PubMed ID: 31348739
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients.
    Leong T; Whitty J; Keilar M; Mifsud S; Ramsay J; Birrell G; Venter D; Southey M; McKay M
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):959-65. PubMed ID: 11072151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
    Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
    Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
    Rothfuss A; Schütz P; Bochum S; Volm T; Eberhardt E; Kreienberg R; Vogel W; Speit G
    Cancer Res; 2000 Jan; 60(2):390-4. PubMed ID: 10667592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage.
    Nieuwenhuis B; Van Assen-Bolt AJ; Van Waarde-Verhagen MA; Sijmons RH; Van der Hout AH; Bauch T; Streffer C; Kampinga HH
    Int J Radiat Biol; 2002 Apr; 78(4):285-95. PubMed ID: 12020440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers.
    Kotsopoulos J; Chen Z; Vallis KA; Poll A; Ainsworth P; Narod SA
    Br J Cancer; 2007 Jan; 96(1):118-25. PubMed ID: 17213827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic exploitation of tumor cell defects in homologous recombination.
    Powell SN; Kachnic LA
    Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility.
    Barwell J; Pangon L; Georgiou A; Kesterton I; Langman C; Arden-Jones A; Bancroft E; Salmon A; Locke I; Kote-Jarai Z; Morris JR; Solomon E; Berg J; Docherty Z; Camplejohn R; Eeles R; Hodgson SV
    Int J Cancer; 2007 Oct; 121(7):1631-6. PubMed ID: 17582599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.
    Buchholz TA; Wu X; Hussain A; Tucker SL; Mills GB; Haffty B; Bergh S; Story M; Geara FB; Brock WA
    Int J Cancer; 2002 Feb; 97(5):557-61. PubMed ID: 11807777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.
    Bernstein JL; Thomas DC; Shore RE; Robson M; Boice JD; Stovall M; Andersson M; Bernstein L; Malone KE; Reiner AS; Lynch CF; Capanu M; Smith SA; Tellhed L; Teraoka SN; Begg CB; Olsen JH; Mellemkjaer L; Liang X; Diep AT; Borg A; Concannon P; Haile RW;
    Eur J Cancer; 2013 Sep; 49(14):2979-85. PubMed ID: 23706288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
    Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
    DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation.
    Trenz K; Rothfuss A; Schütz P; Speit G
    Mutat Res; 2002 Mar; 500(1-2):89-96. PubMed ID: 11890937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.